Once a patient is hit with Progressive External Opthalmoplegia, all ocular motility is lost. Largely, the adult population fall prey to this disease. Double vision is a common symptom among patients who suffer from Opthalmoplegia. In usual terms, Progressive external Opthalmoplegia is known as PEP.
ICD-10 | H49.4 |
ICD-9 | 378.72 |
OMIM | 157640 |
DiseasesDB | 29124 |
eMedicine | oph / 510 |
MeSH | D017246 |
Opthalmoplegia is caused due to disintegration of muscles. When a person is suffering from Opthalmoplegia, the patient always has a tired look on his face.
Occasionally, Progressive external Opthalmoplegia shows the symptoms of specific neurologic syndromes, which contain familial forms of spastic paraplegia, spino-cerebellar disorders, or sensorimotor peripheral neuropathy. Symptoms of the disease appear as early as at the age of 15.
Progressive external Opthalmoplegia is classified as three different categories such as:
A) Progressive External Opthalmoplegia A : Under this category, the disease infects people who are in the age range of 25-35 .
B) Progressive External Opthalmoplegia B: People of age range of 16-25 fall susceptible to the disease.
C) Progressive External Opthalmoplegia C : This is more hereditary in nature as people of 20-30 years of age are prone to the Progressive external Opthalmoplegia C.
There is no viable treatment which can treat the muscle weakness of Progressive External Opthalmoplegia.
Though Coenzyme Q (ubiquinone), akin to Vitamin K, is widely used to treat Progressive external Opthalmoplegia, the degree of success fluctuates.